Abstract
Introduction - Based on favorable survival outcome compared to open repair, thoracic endovascular aortic repair (TEVAR) has become the treatment of choice in the setting of acute complicated type B aortic dissection1. It is increasingly used in treatment of chronic type B aortic dissection (CBAD)2, but the scientific basis for this is scarce. Aortic remodeling after TEVAR has been associated with improved survival, while it has been suggested that lack of aortic remodeling may be associated with worse outcome3.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Vascular and Endovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
